New Nordic Healthbrands AB (publ) (NNH) - Net Assets
Based on the latest financial reports, New Nordic Healthbrands AB (publ) (NNH) has net assets worth Skr102.47 Million SEK (≈ $11.03 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr255.25 Million ≈ $27.47 Million USD) and total liabilities (Skr152.78 Million ≈ $16.44 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check New Nordic Healthbrands AB (publ) (NNH) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr102.47 Million |
| % of Total Assets | 40.14% |
| Annual Growth Rate | 16.23% |
| 5-Year Change | -4.09% |
| 10-Year Change | 181.02% |
| Growth Volatility | 31.21 |
New Nordic Healthbrands AB (publ) - Net Assets Trend (2008–2024)
This chart illustrates how New Nordic Healthbrands AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore NNH current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for New Nordic Healthbrands AB (publ) (2008–2024)
The table below shows the annual net assets of New Nordic Healthbrands AB (publ) from 2008 to 2024. For live valuation and market cap data, see New Nordic Healthbrands AB (publ) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr100.53 Million ≈ $10.82 Million |
-5.19% |
| 2023-12-31 | Skr106.03 Million ≈ $11.41 Million |
-5.81% |
| 2022-12-31 | Skr112.57 Million ≈ $12.11 Million |
-6.44% |
| 2021-12-31 | Skr120.32 Million ≈ $12.95 Million |
+14.80% |
| 2020-12-31 | Skr104.81 Million ≈ $11.28 Million |
+2.84% |
| 2019-12-31 | Skr101.92 Million ≈ $10.97 Million |
+27.06% |
| 2018-12-31 | Skr80.21 Million ≈ $8.63 Million |
+31.91% |
| 2017-12-31 | Skr60.81 Million ≈ $6.54 Million |
+41.49% |
| 2016-12-31 | Skr42.98 Million ≈ $4.63 Million |
+20.15% |
| 2015-12-31 | Skr35.77 Million ≈ $3.85 Million |
+42.75% |
| 2014-12-31 | Skr25.06 Million ≈ $2.70 Million |
+84.95% |
| 2013-12-31 | Skr13.55 Million ≈ $1.46 Million |
+59.93% |
| 2012-12-31 | Skr8.47 Million ≈ $911.72K |
-27.15% |
| 2011-12-31 | Skr11.63 Million ≈ $1.25 Million |
+1.76% |
| 2010-12-31 | Skr11.43 Million ≈ $1.23 Million |
-22.87% |
| 2009-12-31 | Skr14.82 Million ≈ $1.59 Million |
+63.43% |
| 2008-12-31 | Skr9.07 Million ≈ $975.75K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to New Nordic Healthbrands AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5368600000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr39.30 Million | 38.94% |
| Common Stock | Skr6.20 Million | 6.14% |
| Other Comprehensive Income | Skr5.58 Million | 5.53% |
| Other Components | Skr49.85 Million | 49.40% |
| Total Equity | Skr100.92 Million | 100.00% |
New Nordic Healthbrands AB (publ) Competitors by Market Cap
The table below lists competitors of New Nordic Healthbrands AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Scorpion Minerals Ltd
AU:SCN
|
$10.73 Million |
|
SIXTY NORTH GOLD MIN.LTD.
F:2F40
|
$10.74 Million |
|
Vaishali Pharma Limited
NSE:VAISHALI
|
$10.74 Million |
|
AB Panevezio Statybos Trestas
STU:YK3
|
$10.74 Million |
|
Jatcorp Ltd
AU:JAT
|
$10.73 Million |
|
Kier Group PLC
LSE:KIE
|
$10.72 Million |
|
QT Imaging Holdings Inc. Common Stock
NASDAQ:QTI
|
$10.72 Million |
|
Metal Bank Ltd
AU:MBK
|
$10.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in New Nordic Healthbrands AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 106,030,000 to 100,915,000, a change of -5,115,000 (-4.8%).
- Net loss of 7,699,000 reduced equity.
- Other comprehensive income increased equity by 2,583,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-7.70 Million | -7.63% |
| Other Comprehensive Income | Skr2.58 Million | +2.56% |
| Other Changes | Skr1.00K | +0.0% |
| Total Change | Skr- | -4.82% |
Book Value vs Market Value Analysis
This analysis compares New Nordic Healthbrands AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 11.00x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | Skr1.46 | Skr16.10 | x |
| 2009-12-31 | Skr2.39 | Skr16.10 | x |
| 2010-12-31 | Skr1.84 | Skr16.10 | x |
| 2011-12-31 | Skr1.88 | Skr16.10 | x |
| 2012-12-31 | Skr1.37 | Skr16.10 | x |
| 2013-12-31 | Skr2.19 | Skr16.10 | x |
| 2014-12-31 | Skr4.04 | Skr16.10 | x |
| 2015-12-31 | Skr5.77 | Skr16.10 | x |
| 2016-12-31 | Skr6.94 | Skr16.10 | x |
| 2017-12-31 | Skr9.82 | Skr16.10 | x |
| 2018-12-31 | Skr12.95 | Skr16.10 | x |
| 2019-12-31 | Skr16.45 | Skr16.10 | x |
| 2020-12-31 | Skr16.92 | Skr16.10 | x |
| 2021-12-31 | Skr19.42 | Skr16.10 | x |
| 2022-12-31 | Skr18.17 | Skr16.10 | x |
| 2023-12-31 | Skr17.12 | Skr16.10 | x |
| 2024-12-31 | Skr16.29 | Skr16.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently New Nordic Healthbrands AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1.40%
- • Asset Turnover: 2.21x
- • Equity Multiplier: 2.46x
- Recent ROE (-7.63%) is below the historical average (0.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -158.72% | -7.15% | 1.53x | 14.53x | Skr-15.30 Million |
| 2009 | 6.30% | 0.41% | 1.81x | 8.43x | Skr-547.80K |
| 2010 | -50.13% | -2.93% | 1.90x | 9.00x | Skr-6.87 Million |
| 2011 | 2.67% | 0.16% | 2.11x | 8.13x | Skr-852.00K |
| 2012 | -48.23% | -2.01% | 2.22x | 10.83x | Skr-4.93 Million |
| 2013 | 42.67% | 2.54% | 2.53x | 6.66x | Skr4.43 Million |
| 2014 | 49.38% | 4.55% | 2.70x | 4.02x | Skr9.87 Million |
| 2015 | 31.67% | 3.80% | 2.38x | 3.50x | Skr7.75 Million |
| 2016 | 22.28% | 3.13% | 2.40x | 2.97x | Skr5.28 Million |
| 2017 | 33.38% | 5.89% | 2.48x | 2.28x | Skr14.22 Million |
| 2018 | 33.07% | 6.74% | 2.42x | 2.03x | Skr18.50 Million |
| 2019 | 27.55% | 6.20% | 2.30x | 1.93x | Skr17.88 Million |
| 2020 | 16.95% | 3.95% | 2.35x | 1.83x | Skr7.28 Million |
| 2021 | 17.71% | 4.14% | 2.16x | 1.98x | Skr9.27 Million |
| 2022 | -2.51% | -0.58% | 1.94x | 2.24x | Skr-14.08 Million |
| 2023 | -5.84% | -1.16% | 2.14x | 2.35x | Skr-16.80 Million |
| 2024 | -7.63% | -1.40% | 2.21x | 2.46x | Skr-17.79 Million |
Industry Comparison
This section compares New Nordic Healthbrands AB (publ)'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,818,369,024
- Average return on equity (ROE) among peers: 11.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| New Nordic Healthbrands AB (publ) (NNH) | Skr102.47 Million | -158.72% | 1.49x | $10.73 Million |
| AAK AB (AAK) | $9.74 Billion | 16.05% | 1.29x | $7.38 Billion |
| Humble Group AB (HUMBLE) | $4.89 Billion | 0.35% | 0.80x | $352.54 Million |
| Lohilo Foods AB (LOHILO) | $4.04 Million | 47.61% | 2.15x | $6.57 Million |
| Midsona AB (publ) (MSON-A) | $710.00 Million | 7.18% | 0.65x | $624.80K |
| Midsona AB (publ) (MSON-B) | $877.00 Million | 7.53% | 0.77x | $192.72 Million |
| Scandi Standard publ AB (SCST) | $1.06 Billion | 26.57% | 0.99x | $1.05 Billion |
| Swedencare publ AB (SECARE) | $8.03 Billion | 1.23% | 0.28x | $462.72 Million |
| Skane mollan AB (SKMO) | $57.00 Million | 19.30% | 0.62x | $65.11 Million |
| Premium Snacks Nordic AB (SNX) | $4.38 Million | -21.88% | 1.84x | $61.70 Million |
About New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) develops and markets dietary supplements, herbal pharmaceutical, and personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and… Read more